248 related articles for article (PubMed ID: 17148582)
21. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
[TBL] [Abstract][Full Text] [Related]
22. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.
Scheinberg P; Nunez O; Weinstein B; Scheinberg P; Biancotto A; Wu CO; Young NS
N Engl J Med; 2011 Aug; 365(5):430-8. PubMed ID: 21812672
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
[TBL] [Abstract][Full Text] [Related]
24. Active CMV and EBV infections in renal transplant recipients with unexplained fever and elevated serum creatinine.
Hasannia T; Moosavi Movahed SM; Vakili R; Rafatpanah H; Hekmat R; Valizadeh N; Rezaee SA
Ren Fail; 2016 Oct; 38(9):1418-1424. PubMed ID: 27484706
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
Sumi M; Watanabe M; Sato K; Shimizu I; Ueki T; Akahane D; Ueno M; Ichikawa N; Asano N; Kobayashi H
Rinsho Ketsueki; 2011 Nov; 52(11):1782-7. PubMed ID: 22185802
[TBL] [Abstract][Full Text] [Related]
26. Monitoring of EBV reactivation is justified in patients with aplastic anemia treated with rabbit ATG as a second course of immunosuppression.
Wondergem MJ; Stevens SJ; Janssen JJ; Oudejans JJ; Ossenkoppele GJ; Middeldorp JM; Zweegman S
Blood; 2008 Feb; 111(3):1739; author reply 1739-40. PubMed ID: 18223173
[No Abstract] [Full Text] [Related]
27. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
[TBL] [Abstract][Full Text] [Related]
28. Immune reconstitution and cytomegalovirus infection after allogeneic stem cell transplantation: the important impact of in vivo T cell depletion.
Schmidt-Hieber M; Schwarck S; Stroux A; Ganepola S; Reinke P; Thiel E; Uharek L; Blau IW
Int J Hematol; 2010 Jun; 91(5):877-85. PubMed ID: 20490728
[TBL] [Abstract][Full Text] [Related]
29. Rapidly progressive Epstein-Barr virus-associated lymphoproliferative disorder unpredictable by weekly viral load monitoring.
Wakabayashi S; Ohashi K; Hanajiri R; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Intern Med; 2010; 49(10):931-5. PubMed ID: 20467179
[TBL] [Abstract][Full Text] [Related]
30. Cytomegalovirus and Epstein-Barr virus reactivation in the intensive care unit.
Coşkun O; Yazici E; Şahiner F; Karakaş A; Kiliç S; Tekin M; Artuk C; Yamanel L; Beşirbellioğlu BA
Med Klin Intensivmed Notfmed; 2017 Apr; 112(3):239-245. PubMed ID: 27435067
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus associated pneumonia in an adult patient with severe aplastic anaemia: resolution after the transient withdrawal of cyclosporine.
Potenza L; Barozzi P; Codeluppi M; Morselli M; Forghieri F; Volzone F; Riva G; Pietrosemoli P; Pecorari M; Leonardi G; Torelli G; Luppi M
Am J Hematol; 2007 Oct; 82(10):944-6. PubMed ID: 17617784
[No Abstract] [Full Text] [Related]
32. Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study.
Scheinberg P; Wu CO; Nunez O; Scheinberg P; Boss C; Sloand EM; Young NS
Haematologica; 2009 Mar; 94(3):348-54. PubMed ID: 19181786
[TBL] [Abstract][Full Text] [Related]
33. Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy.
O'Brien S; Ravandi F; Riehl T; Wierda W; Huang X; Tarrand J; O'Neal B; Kantarjian H; Keating M
Blood; 2008 Feb; 111(4):1816-9. PubMed ID: 18039954
[TBL] [Abstract][Full Text] [Related]
34. The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.
Delgado J; Pillai S; Benjamin R; Caballero D; Martino R; Nathwani A; Lovell R; Thomson K; Perez-Simon JA; Sureda A; Kottaridis P; Vazquez L; Peggs K; Sierra J; Milligan D; Mackinnon S
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1288-97. PubMed ID: 18940684
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive therapy (IST) in adult patients with acquired aplastic anemia (AA): A single-center experience over the past 15 years.
Alashkar F; Oelmüller M; Herich-Terhürne D; Turki AT; Schmitz C; Vance C; Dührsen U; Röth A
Eur J Haematol; 2019 Jul; 103(1):18-25. PubMed ID: 30977158
[TBL] [Abstract][Full Text] [Related]
36. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
[TBL] [Abstract][Full Text] [Related]
37. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.
Chakrabarti S; Mackinnon S; Chopra R; Kottaridis PD; Peggs K; O'Gorman P; Chakraverty R; Marshall T; Osman H; Mahendra P; Craddock C; Waldmann H; Hale G; Fegan CD; Yong K; Goldstone AH; Linch DC; Milligan DW
Blood; 2002 Jun; 99(12):4357-63. PubMed ID: 12036862
[TBL] [Abstract][Full Text] [Related]
38. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
Kullberg-Lindh C; Olofsson S; Brune M; Lindh M
Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
[TBL] [Abstract][Full Text] [Related]
39. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
40. Alemtuzumab, fludarabine and melphalan as a conditioning therapy in severe aplastic anemia and hypoplastic myelodysplastic syndrome--single center experience.
Rzepecki P; Sarosiek T; Szczylik C
Jpn J Clin Oncol; 2006 Jan; 36(1):46-9. PubMed ID: 16423840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]